6466-0999 Screening compound: 5-(furan-2-yl)-N-[(4-methylphenyl)methyl]-7-(trifluoromethyl)-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-2-carboxamide

6466-0999 Screening compound: 5-(furan-2-yl)-N-[(4-methylphenyl)methyl]-7-(trifluoromethyl)-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-2-carboxamide
6466-0999 Screening compound: 5-(furan-2-yl)-N-[(4-methylphenyl)methyl]-7-(trifluoromethyl)-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 6466-0999
5-(furan-2-yl)-N-[(4-methylphenyl)methyl]-7-(trifluoromethyl)-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

6466-0999

Molecular Formula

C20H19F3N4O2 (C20 H19 F3 N4 O2)

Compound Name

5-(furan-2-yl)-N-[(4-methylphenyl)methyl]-7-(trifluoromethyl)-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-2-carboxamide

IUPAC name

(5R7S)-5-(furan-2-yl)-N-[(4-methylphenyl)methyl]-7-(trifluoromethyl)-4H5H6H7H-pyrazolo[15-a]pyrimidine-2-carboxamide

SMILES

Cc1ccc(CNC(c2nn([C@H](C[C@@H](c3ccco3)N3)C(F)(F)F)c3c2)=O)cc1

InChI

InChI=1S/C20H19F3N4O2/c1-12-4-6-13(7-5-12)11-24-19(28)15-10-18-25-14(16-3-2-8-29-16)9-17(20(21,22)23)27(18)26-15/h2-8,10,14,17,25H,9,11H2,1H3,(H,24,28)/t14-,17-/m1/s1

InChI Key

IPLMLJAAINZKEL-RHSMWYFYSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

404.39

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.847

Distribution Coefficient, logD

3.847

Water Solubility, LogSw

-3.85

Polar Surface Area

60.758

Acid Dissociation Constant (pKa)

13.11

Base Dissociation Constant (pKb)

-3.47

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

30.00

6466-0999 in Drug Discovery

Included in Screening Libraries

3D Mimetics PPI Library (1617 compounds)

Protein-Protein Interaction Library (218420 compounds)

Voltage-Gated Ion Channel-Targeted Library (4740 compounds)

Epigenetics Focused Set (26518 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Structure:
  • Mimetics
  • 3D
Mechanism of action:
  • PPI modulators
Therapeutical areas:
  • Nervous system
Targets:
  • Ion Channels

References: we are preparing a list of scientific research reports with 6466-0999 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 6466-0999?
Check Price and Availability of 6466-0999, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 6466-0999 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 6466-0999
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 6466-0999
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 6466-0999 available by request